EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RNA Metabolism Genes as Prognostic Biomarkers and Therapeutic Targets in Colorectal Cancer Based on the Analysis of Single‐Cell and Bulk‐ RNA Sequencing Data

Fandong Kong, Xuewei Zhang, Shuguang Su, Feilong Chen, Qiantao Ye, Ronghua Yang iD, Hanpeng Du

Journal of Cellular and Molecular Medicine · 2026-06 · 30 (11)

DOI: 10.1111/jcmm.71236 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 10.06.2026. Verfasst von Fandong Kong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Panyu Maternal and Child Care Service Centre of Guangzhou (He Xian Memorial Affiliated Hospital of Southern M…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Biomarkers, Tumor, RNA. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chongqing Traditional Chinese Medicine Inheritance and Innovation Team.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is one of the most common malignancies worldwide and remains a major cause of cancer‐related mortality. Increasing evidence suggests that aberrant RNA metabolism contributes to tumour initiation, progression and therapeutic resistance. In this study, we integrated single‐cell RNA sequencing and bulk transcriptomic data to identify RNA metabolism‐related genes (RMRGs) associated with CRC progression and evaluate their clinical significance. Through comprehensive bioinformatics analyses, 39 differentially expressed RMRGs were identified, with high RMRG activity predominantly enriched in epithelial cell populations. Cell–cell communication analysis revealed enhanced interactions between epithelial cells and other cell types within the tumour microenvironment. Further integration of single‐cell and bulk RNA‐sequencing datasets identified PCBP3 and NGRN as key prognostic genes. A two‐gene prognostic model based on PCBP3 and NGRN was established and validated in independent cohorts, demonstrating favourable predictive performance. Human Protein Atlas data further confirmed the expression of both proteins in colorectal cancer tissues. Immune infiltration analyses indicated that PCBP3 and NGRN were associated with distinct immune‐cell infiltration patterns and immunotherapy‐related immune status. Functional experiments demonstrated that silencing PCBP3 or NGRN significantly inhibited the proliferation and invasion of HCT116 colorectal cancer cells. Moreover, Western blot analysis suggested that these effects may be mediated, at least in part, through regulation of the PI3K/AKT signalling pathway. Collectively, our findings identify PCBP3 and NGRN as promising prognostic biomarkers and potential therapeutic targets in colorectal cancer and provide new insights into the role of RNA metabolism in colorectal cancer progression and tumour immune regulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsBiomarkers, TumorRNAHumansPrognosisGene Expression Regulation, NeoplasticRNA-Binding ProteinsTumor MicroenvironmentSequence Analysis, RNASingle-Cell Gene Expression AnalysisSingle-Cell AnalysisSignal TransductionGene Expression ProfilingComputational Biology

Stichwörter der Autor:innen

RNA metabolism‐related genesbulk‐RNA sequencing datacolorectal cancerprognostic biomarkerssingle‐cell sequencing data

Substanzen

Biomarkers, TumorRNA-Binding ProteinsRNA

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, Panyu Maternal and Child Care Service Centre of Guangzhou (He Xian Memorial Affiliated Hospital of Southern Medical University), Guangzhou, Guangdong, China.
  • Department of Burn and Plastic Surgery, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Department of Pathology, Panyu Maternal and Child Care Service Centre of Guangzhou (He Xian Memorial Affiliated Hospital of Southern Medical University), Guangzhou, Guangdong, China.

ORCID-Profile: Ronghua Yang

Förderung

  • Chongqing Traditional Chinese Medicine Inheritance and Innovation Team

Zitieren

APA

Kong, F., Zhang, X., Su, S., Chen, F., Ye, Q., Yang, R., & Du, H. (2026). RNA Metabolism Genes as Prognostic Biomarkers and Therapeutic Targets in Colorectal Cancer Based on the Analysis of Single‐Cell and Bulk‐ RNA Sequencing Data. Journal of Cellular and Molecular Medicine, 30(11). https://doi.org/10.1111/jcmm.71236

Vancouver

Kong F, Zhang X, Su S, Chen F, Ye Q, Yang R, et al. RNA Metabolism Genes as Prognostic Biomarkers and Therapeutic Targets in Colorectal Cancer Based on the Analysis of Single‐Cell and Bulk‐ RNA Sequencing Data. Journal of Cellular and Molecular Medicine. 2026;30(11). doi:10.1111/jcmm.71236

BibTeX
@article{Kong2026,
  author = {Kong, Fandong and Zhang, Xuewei and Su, Shuguang and Chen, Feilong and Ye, Qiantao and Yang, Ronghua and Du, Hanpeng},
  title = {RNA Metabolism Genes as Prognostic Biomarkers and Therapeutic Targets in Colorectal Cancer Based on the Analysis of Single‐Cell and Bulk‐ RNA Sequencing Data},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  volume = {30},
  number = {11},
  doi = {10.1111/jcmm.71236}
}
Kostenlos starten →